This link between the tumor cell hypoxic response and immune-suppression is corroborated by evidence that HIF1a activation in tumor cells results in a mesenchymal shift and expression of immunosuppressive genes and is linked with poor patient survival and tumor recurrence (Joseph et al., 2015; Sattiraju et al., 2023). The gene discussed is HIF1A; the disease is neoplasm.